| Ident. | Authors (with country if any) | Title |
|---|
| 000152 |
Vincent Pavot [Royaume-Uni] ; Morgane Berthet [France] ; Julien Resseguier [France] ; Sophie Legaz [France] ; Nadège Handke [France] ; Sarah C. Gilbert [Royaume-Uni] ; Stéphane Paul [France] ; Bernard Verrier [France] | Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery |
| 000216 |
L. Alemany [Espagne] ; M. Saunier [Espagne] ; L. Tinoco [Équateur] ; B. Quiros [Espagne] ; I. Alvarado-Cabrero [Mexique] ; M. Alejo [Espagne] ; E. A. Joura [Autriche] ; P. Maldonado [Brésil] ; J. Klaustermeier [Espagne] ; J. Salmeron [Mexique] ; C. Bergeron [France] ; K. U. Petry [Allemagne] ; N. Guimera [Pays-Bas] ; O. Clavero [Espagne] ; R. Murillo [Colombie] ; C. Clavel [France] ; V. Wain [Australie] ; D. T. Geraets [Pays-Bas] ; R. Jach [Pologne] ; P. Cross [Royaume-Uni] ; C. Carrilho [Mozambique] ; C. Molina [Chili] ; H. R. Shin [Corée du Sud] ; V. Mandys [République tchèque] ; A. M. Nowakowski [Pologne] ; A. Vidal [Espagne] ; L. Lombardi [Guatemala] ; H. Kitchener [Royaume-Uni] ; A. R. Sica [Uruguay] ; C. Magana-Leon ; M. Pawlita ; W. Quint [Pays-Bas] ; I. G. Bravo [Espagne] ; N. Munoz ; S. De Sanjose [Espagne] ; F. X. Bosch [Espagne] | Large contribution of human papillomavirus in vaginal neoplastic lesions: A worldwide study in 597 samples |
| 000281 |
Asad Ali [Pakistan] ; RABAB ZEHRA JAFRI [Pakistan, États-Unis] ; Nancy Messonnier [États-Unis] ; Carol Tevi-Benissan [Suisse] ; David Durrheim [Australie] ; Juhani Eskola [Finlande] ; Florence Fermon [France] ; Keith P. Klugman [États-Unis, Afrique du Sud] ; Mary Ramsay [Royaume-Uni] ; Samba Sow [Mali, États-Unis] ; SHAO ZHUJUN [République populaire de Chine] ; Zulfiqar Bhutta [Pakistan] ; Jon Abramson [États-Unis] | Global practices of meningococcal vaccine use and impact on invasive disease |
| 000574 |
Lorenz Von Seidlein [Australie] ; Mohammad Jiddawi [Tanzanie] ; Rebecca F. Grais [France] ; Francisco Luquero [France] ; Marcelino Lucas [Mozambique] ; Jacqueline Deen [Australie] | The Value of and Challenges for Cholera Vaccines in Africa |
| 000773 |
Francesca Poli [Italie] ; Sebastiaan Overeem [Pays-Bas] ; Gert Jan Lammers [Pays-Bas] ; Giuseppe Plazzi [Italie] ; Michel Lecendreux [France] ; Claudio L. Bassetti [Suisse] ; Yves Dauvilliers [France] ; Daniel Keene [Canada] ; Ramin Khatami [Suisse] ; YULIN LI [Suisse] ; Geert Mayer [Allemagne] ; Hanna Nohynek [Finlande] ; Barbara Pahud [États-Unis] ; Teresa Paiva [Portugal] ; Markku Partinen [Finlande] ; Thomas E. Scammell [États-Unis] ; Tom Shimabukuro [États-Unis] ; Miriam Sturkenboom [Pays-Bas] ; Kristy Van Dinther [Australie] ; Max Wiznitzer [États-Unis] ; Jan Bonhoeffer [Suisse] | Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation |
| 001760 |
MING QIAO [Australie, France, Thaïlande] ; David Shaw ; Remi Forrat ; Anh Wartel-Tram ; Jean Lang | Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans |
| 001764 |
SAI KIT LAM [Malaisie] ; Donald Burke [États-Unis] ; Maria Rosario Capeding [Philippines] ; Chee Keong Chong [Malaisie] ; Laurent Coudeville [France] ; Jeremy Farrar [Namibie] ; Duane Gubler [Singapour] ; Sri Rezeki Hadinegoro [Indonésie] ; Jeffrey Hanna [Australie] ; Jean Lang [France] ; HAN LIM LEE [Malaisie] ; YEE SIN LEO [Singapour] ; CHAN QUANG LUONG [Namibie] ; Richard Mahoney [Corée du Sud] ; John Mcbride [Australie] ; Jorge Mendez-Galvan [Mexique] ; LEE CHING NG [Singapour] ; Suchitra Nimmannitya [Thaïlande] ; ENG EONG OOI [Singapour] ; Donald Shepard [États-Unis] ; Jaco Smit [France] ; Rémy Teyssou [France] ; Laurent Thomas [France] ; Joseph Torresi [Australie] ; Pedro Vasconcelos [Brésil] ; Dewa Nyoman Wirawan [Indonésie] ; Sutee Yoksan [Thaïlande] | Preparing for introduction of a dengue vaccine: Recommendations from the 1 st Dengue v2V Asia-Pacific Meeting |
| 001944 |
O. Reynard [France] ; V. Mokhonov [Australie] ; E. Mokhonova [Australie] ; J. Leung [Australie] ; A. Page [France] ; M. Mateo [France] ; O. Pyankova [Australie] ; M. C. Georges-Courbot [France] ; H. Raoul [France] ; A. A. Khromykh [Australie] ; V. E. Volchkov [France] | Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection |
| 001A05 |
Pierre Van Damme [Belgique] ; Peter Mcintyre [Australie] ; Emmanuel Grimprel [France] ; Sherine Kuriyakose [Inde] ; Jeanne-Marie Jacquet [Belgique] ; Karin Hardt [Belgique] ; Marc Messier [Belgique] ; Olivier Van Der Meeren [Belgique] | Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials |
| 001F67 |
Terry M. Nolan [Australie] | The Australian model of immunization advice and vaccine funding |
| 002348 |
F. M. Russell [Australie] ; J. R. Carapetis [Australie] ; A. Balloch [Australie] ; P. V. Licciardi [Australie] ; A. W. J. Jenney [Australie] ; L. Tikoduadua [Fidji] ; L. Waqatakirewa [Fidji] ; J. Pryor [Fidji] ; J. Nelson [Australie] ; G. B. Byrnes [France] ; Y. B. Cheung [Singapour] ; M. L. K. Tang [Australie] ; E. K. Mulholland [Australie, Royaume-Uni] | Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial |
| 002428 |
Nadine L. Dudek [Australie] ; Patrick Perlmutter [Australie] ; Marie-Isabel Aguilar [Australie] ; Nathan P. Croft [Australie] ; Anthony W. Purcell [Australie] | Epitope Discovery and Their Use in Peptide Based Vaccines |
| 002462 |
J. Castilla [Espagne] ; J. Moran [Espagne] ; V. Martinez-Artola [Espagne] ; G. Reina [Espagne] ; I. Martinez-Baz [Espagne] ; M. Garcia Cenoz [Espagne] ; N. Alvarez [Espagne] ; F. Irisarri [Espagne] ; M. Arriazu [Espagne] ; F. Elia [Espagne] ; E. Salcedo [Espagne] | Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis |
| 002463 |
C. Savulescu [Espagne, France] ; S. Jimenez-Jorge [Espagne] ; S. De Mateo [Espagne] ; J. Ledesma [Espagne] ; F. Pozo [Espagne] ; I. Casas [Espagne] ; A. Larrauri [Espagne] | Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study |
| 002464 |
S. Jefferies [Nouvelle-Zélande] ; D. Earl [Nouvelle-Zélande] ; N. Berry [Nouvelle-Zélande] ; T. Blackmore [Nouvelle-Zélande] ; S. Rooker [Nouvelle-Zélande] ; N. Raymond [Nouvelle-Zélande] ; A. Pritchard [Nouvelle-Zélande] ; M. Weatherall [Nouvelle-Zélande] ; R. Beasley [Nouvelle-Zélande] ; K. Perrin [Nouvelle-Zélande] | Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009 |
| 002465 |
R. Pebody [Royaume-Uni] ; P. Hardelid [Royaume-Uni] ; D. M. Fleming [Royaume-Uni] ; J. Mcmenamin [Royaume-Uni] ; N. Andrews [Royaume-Uni] ; C. Robertson [Royaume-Uni] ; D. R. Thomas [Royaume-Uni] ; P. Sebastian Pillai [Royaume-Uni] ; J. Ellis [Royaume-Uni] ; W. Carman [Royaume-Uni] ; T. Wreghitt [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; J. M. Watson [Royaume-Uni] | Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11 |
| 002466 |
P. Hardelid [Royaume-Uni] ; D. M. Fleming [Royaume-Uni] ; J. Mcmenamin [Royaume-Uni] ; N. Andrews [Royaume-Uni] ; C. Robertson [Royaume-Uni] ; P. Sebastianpillai [Royaume-Uni] ; J. Ellis [Royaume-Uni] ; W. Carman [Royaume-Uni] ; T. Wreghitt [Royaume-Uni] ; J. M. Watson [Royaume-Uni] ; R. G. Pebody [Royaume-Uni] | Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010 |
| 002479 |
E. Kissling [France] ; M. Valenciano [France] | Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study |
| 002A68 |
D. Schadendorf [Allemagne] ; S. M. Algarra [Espagne] ; L. Bastholt [Danemark] ; G. Cinat [Argentine] ; B. Dreno [France] ; A. M. M. Eggermont [Pays-Bas] ; E. Espinosa [Espagne] ; J. Guo [République populaire de Chine] ; A. Hauschild [Allemagne] ; T. Petrella [Canada] ; J. Schachter [Israël] ; P. Hersey [Australie] | Immunotherapy of distant metastatic disease |
| 002A69 |
F. M. Russell [Australie] ; A. Balloch [Australie] ; M. L. K. Tang [Australie] ; J. R. Carapetis [Australie] ; P. Licciardi [Australie] ; J. Nelson [Australie] ; A. W. J. Jenney [Australie] ; L. Tikoduadua [Fidji] ; L. Waqatakirewa [Fidji] ; J. Pryor [Fidji] ; G. B. Byrnes [France] ; Y. B. Cheung [Singapour] ; E. K. Mulholland [Australie, Royaume-Uni] | Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine |
| 002A70 |
Francesco Pappalardo [Royaume-Uni] ; Mark D. Halling-Brown ; Nicolas Rapin ; PING ZHANG [Australie] ; Davide Alemani [Suisse] ; Andrew Emerson [Royaume-Uni] ; Paola Paci [Italie] ; Patrice Duroux [France] ; Marzio Pennisi [Royaume-Uni] ; Arianna Palladini [Italie] ; Olivo Miotto [Royaume-Uni] ; Daniel Churchill [Hong Kong] ; Elda Rossi [Italie] ; Adrian J. Shepherd [Royaume-Uni] ; David S. Moss [Royaume-Uni] ; Filippo Castiglione [Italie] ; Massimo Bernaschi ; Marie-Paule Lefranc [France] ; Soren Brunak ; Santo Motta [Royaume-Uni] ; Pier-Luigi Lollini [Italie] ; Kaye E. Basford [Australie] ; Vladimir Brusic [États-Unis] | ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization |
| 003132 |
Janet E. Mcelhaney [États-Unis, Canada] ; Jan P. Dutz [Canada] ; David Holland [Nouvelle-Zélande] ; Robert Booy [Australie] ; Ferdinandus De Looze [Australie] ; Peter Eizenberg [Australie] ; James Mcdonald [Australie] ; Jeff Karrasch [Australie] ; Maureen Mckeirnan [Australie] ; Hatem Salem [Australie] ; Graham Mills [Nouvelle-Zélande] ; Jim Reid [Nouvelle-Zélande] ; Francoise Weber [France] ; Melanie Saville [France] | Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults : A Randomized Controlled Trial. Commentary |
| 003293 |
E. A. Gould [France, Royaume-Uni] ; T. Solomon [Royaume-Uni] ; J. S. Mackeuzie [Australie] | Does antiviral therapy have a role in the control of Japanese encephalitis? |
| 003364 |
Bruno Guy [France] ; Nolwenn Nougarede [France] ; Sarah Begue [France] ; Violette Sanchez [France] ; Nadia Souag [France] ; Murielle Carre [France] ; Laurent Chambonneau [France] ; Dennis N. Morrisson [États-Unis] ; David Shaw [Australie] ; MING QIAO [Australie] ; Rafaele Dumas [France] ; Jean Lang [France] ; Remi Forrat [France] | Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects |
| 003545 |
Pierre Vandepapeliere [Belgique] ; George K. K. Lau [Hong Kong] ; Geert Leroux-Roels [Belgique] ; Yves Horsmans [Belgique] ; Edward Gane [Nouvelle-Zélande] ; Tawesak Tawandee [Thaïlande] ; MOHD ISMAIL BIN MERICAN [Malaisie] ; KHIN MAUNG WIN [Birmanie] ; Christian Trepo [France] ; Graham Cooksley [Australie] ; Martine Wettendorff [Belgique] ; Carlo Ferrari [Italie] | Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy : A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine |
| 003643 |
Julie Sheldon [Espagne] ; Belen Ramos [Espagne] ; Javier Garcia-Samaniego ; Pilar Rios [Espagne] ; Angeline Bartholomeusz [Australie] ; Miriam Romero ; Stephen Locarnini [Australie] ; Fabien Zoulim [France] ; Vincent Soriano [Espagne] | Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity |
| 003828 |
Daniel J. Isaacman [États-Unis] ; Mark A. Fletcher [France] ; Bernard Fritzell [France] ; Vincent Ciuryla [États-Unis] ; Jennifer Schranz [États-Unis] | Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar) |
| 003932 |
Keith Grimwood [Australie] ; Julie E. Bines [Australie] ; T. Vesikari [Finlande] ; A. Karvonen [Finlande] ; R. Prymula [République tchèque] ; V. Schuster [Allemagne] ; J. C. Tejedor [Espagne] ; R. Cohen [France] ; F. Meurice [Belgique] ; H. H. Han [Belgique] ; S. Damaso [Belgique] ; A. Bouckenooghe [Belgique] | Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants : randomised, double-blind controlled study. Commentary |
| 003986 |
Els N. T. Meeusen [Australie] ; John Walker [Australie] ; Andrew Peters [Royaume-Uni] ; Paul-Pierre Pastoret [France] ; Gregers Jungersen [Danemark] | Current status of veterinary vaccines |
| 003A29 |
Mark A. Fletcher [France] ; Bernard Fritzell [France] | Brief review of the clinical effectiveness of PREVENAR® against otitis media |
| 003F63 |
Scott Kitchener [Australie] ; Michael Nissen [Australie] ; Peter Nasveld [Australie] ; Remi Forrat [France] ; Sutee Yoksan [Thaïlande] ; Jean Lang [France] ; Jean-Francois Saluzzo [France] | Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults |
| 004248 |
Marie Paule Kieny [Suisse] ; Alejandro Costa [Suisse] ; Joachim Hombach [Suisse] ; Peter Carrasco [Suisse] ; Yuri Pervikov [Suisse] ; David Salisbury [Royaume-Uni] ; Michel Greco ; Ian Gust [Australie] ; Marc Laforce [France] ; Carlos Franco-Paredes [Mexique] ; José Ignacio Santos [Mexique] ; Eric D'Hondt [Belgique] ; Guus Rimmelzwaan [Pays-Bas] ; Ruth Karron [États-Unis] ; Keiji Fukuda [Suisse] | A global pandemic influenza vaccine action plan |
| 004263 |
M. A. Charveriat ; M. Chomarat [France] ; M. Watson [Australie] ; B. Garin | Étude du portage rhinopharyngé de Streptococcus pneumoniae chez les enfants sains âgés de 2 à 24 mois en Nouvelle-Calédonie |
| 004331 |
D. E. Webster [Australie] ; M. C. Thomas [Australie] ; Z. Huang [Australie] ; S. L. Wesselingh [Australie] | The development of a plant-based vaccine for measles |
| 004447 |
Ian Polkinghome [Australie] ; Denes Hamerli [Australie] ; Phil Cowan [Nouvelle-Zélande] ; Janine Duckworth [Nouvelle-Zélande] | Plant-based immunocontraceptive control of wildlife : "potentials, limitations, and possums" |
| 004555 |
Rajesh Tim Gandhi [États-Unis] ; Marcus Altfeld [États-Unis] ; Sabine Kinloch-De Loes [Royaume-Uni] ; Bruno Hoen [France] ; Don E. Smith [Australie] ; Brigitte Autran [France] ; Fiona C. Lampe [Royaume-Uni] ; Andrew N. Phillips [Royaume-Uni] ; Li-Ean Goh [Royaume-Uni] ; Jan Andersson [Suède] ; Christos Tsoukas [Canada] ; Anders Sonnerborg [Suède] ; Giuseppe Tambussi [Italie] ; Pierre-Marie Girard [France] ; Mark Bloch [Australie] ; Manuel Battegay [Swaziland] ; Nick Carter [Royaume-Uni] ; Raphaelle El Habib [France] ; Georgia Theofan [États-Unis] ; David A. Cooper [Australie] ; Luc Perrin [Suisse] | Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. Commentary |
| 004855 |
M. W. Lightowlers [Australie] | Vaccination for the prevention of cysticercosis |
| 004A40 |
Eugene Maraskovsky [Australie] ; Sigrid Sjölander [Australie] ; Debbie P. Drane [Australie] ; Max Schnurr [Australie] ; Thuy T. T. Le [Australie] ; Luis Mateo [Australie] ; Thomas Luft [Australie] ; Kelly-Anne Masterman [Australie] ; Tsin-Yee Tai [Australie] ; QIYUAN CHEN [Australie] ; Simon Green [Australie] ; Anders Sjölander [Australie] ; Martin J. Pearse [Australie] ; Francois A. Lemonnier [France] ; WEISAN CHEN [Australie] ; Jonathan Cebon [Australie] ; Andreas Suhrbier [Australie] | NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ T-cell-mediated immunity and protection against NY-ESO-1+ tumors |
| 004A41 |
Rachel Pinto [Australie] ; Bernadette M. Saunders [Australie] ; Luis R. Camacho [France] ; Warwick J. Britton [Australie] ; Brigitte Gicquel [France] ; James A. Triccas [Australie] | Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine |
| 004C45 |
Joseph Monsonego [France] ; F. Xavier Bosch [Espagne] ; Pierre Coursaget [France] ; John Thomas Cox [États-Unis] ; Eduardo Franco [Canada] ; Ian Frazer [Australie] ; Rengaswamy Sankaranarayanan [France] ; John Schiller [États-Unis] ; Albert Singer [Royaume-Uni] ; Torn Wright [États-Unis] ; Walter Kinney [États-Unis] ; Chris Meijer [Pays-Bas] ; James Linder [États-Unis] | Cervical cancer control, priorities and new directions |
| 004C65 |
N. E. Tweddle [Australie] | Australian contingency plans for emergency animal disease control : the role of antigen/vaccine banks |
| 004D92 |
Deborah Lehmann [Papouasie-Nouvelle-Guinée, Australie] ; William S. Pomat [Papouasie-Nouvelle-Guinée, Australie] ; Ian D. Riley [Australie] ; Michael P. Alpers [Papouasie-Nouvelle-Guinée, Australie] | Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea |
| 005006 |
P. G. Holt [Australie] ; J. Rowe [Australie] ; R. Loh [Australie] ; P. D. Sly [Australie] | Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood |
| 005255 |
J. Armand [France] | Regulatory barrier to new vaccine development... Thinking outside the box |
| 005360 |
T. P. Monath [États-Unis] | Japanese encephalitis vaccines: Current vaccines and future prospects |
| 005387 |
I. Kurane [Japon] | Immune responses to Japanese encephalitis virus |
| 005632 |
J. Miller [Australie] ; D. Becker [Australie] ; B. Dugdale [Australie] ; R. Harding [Australie] ; J. Aaskov [Australie] ; I. Frazer [Australie] ; J. Dale [Australie] | Towards the development of edible vaccines for human papillomavirus in bananas |
| 005902 |
S. M. Lee [Australie] ; I. G. Polkinghorne [Australie] ; A. M. Walmsley [Australie, États-Unis] ; D. Hamerli [Australie] ; K. Mouradova [Australie] ; J. A. Duckworth [Australie, Nouvelle-Zélande] ; K. E. Mate [Australie] ; G. A. Smith [Australie] ; P. L. Young [Australie] | Development of plant-based immunocontraceptive vaccines for marsupials |
| 005933 |
E. Martin [États-Unis, France] ; J. A. Triccas [États-Unis] ; A. T. Kamath [États-Unis] ; N. Winter [France] ; W. J. Britton [États-Unis, Australie] | Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection |
| 005C25 |
B. Acres [France] ; V. Apostolopoulos [Australie] ; J.-M. Balloul [France] ; D. Wreschner [Israël] ; P.-X. Xing [Australie] ; D. Ali-Hadji [France] ; N. Bizouarne [France] ; M. P. Kieny [France] ; I. F. C. Mckenzie [Australie] | MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines |
| 005C53 |
Catherine J. Lees [Australie] ; Vasso Apostolopoulos [Australie] ; Bruce Acres [France] ; Ian Ramshaw [Australie] ; Alistair Ramsay [Australie] ; Chin-Swee Ong [Australie] ; Ian F. C. Mckenzie [Australie] | Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice |
| 005D19 |
J. T. Poolman [Belgique] ; L. Bakaletz [États-Unis] ; A. Cripps [Australie] ; P. A. Denoel [Belgique] ; A. Forsgren [Suède] ; J. Kyd [Australie] ; Y. Lobet [Belgique] | Developing a nontypeable Haemophilus influenzae (NTHi) vaccine |
| 005E34 |
K. Redhead [Royaume-Uni] ; R. Lucken [Royaume-Uni] ; A. V. De Moer [France] ; S. Houghton [Royaume-Uni] ; B. Simpson [Nouvelle-Zélande] ; A. Cameron [Australie] ; P. Monkton [Australie] ; K. Hennesy [États-Unis] ; C. Ellis [Afrique du Sud] | Veterinary vaccines : In-VITRO : International Veterinary Industry Test Replacement Organisation |
| 006B16 |
P. J. Coloe [Australie] ; M. R. Alderton ; N. L. Gerraty ; W. Christopher ; S. C. Smith | Aromatic vitamin-dependent Salmonellae as vaccines in food animals: efficacy and persistence |
| 006B28 |
P. A. Manning [Australie] | A beginning to cell surface studies in Vibrio cholerae : a personal perspective |
